Featured News
APR 2020
A Spanish-Swiss Liaison to fight COVID-19
APR 2020
InterAx Biotech supporting the COVID-19 initiative SARS-CoV-2/ACE-2 pseudovirus entry blocking assay
DEC 2019
InterAx Biotech and GPCR Therapeutics Inc collaborate for the identification of compounds with superior biological properties targeting GPCR heteromers